Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Senior Corporate Counsel, Contracts (Clinical Development) will support the Company’s clinical research and development activities by drafting, negotiating, and advising on a broad range of clinical and research-related agreements. This role partners closely with Clinical Development, Clinical Operations, Biometrics, Medical Affairs, Procurement, and Legal and Compliance teams to enable efficient and compliant execution of clinical programs. The ideal candidate has strong experience with clinical trial agreements and related contracts in a biotech or pharmaceutical setting, excellent judgment, and the ability to manage multiple priorities in a fast-paced environment.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Education Level
Ph.D. or professional degree
Number of Employees
251-500 employees